India will comply with EU API standards; Xcelience opens new facility in FL;

> The Indian government is planning to comply with the EU's regulations on API exporters, saying it will appoint a "competent authority" to ensure that standards are met. News

> ShangPharma has entered a licensing agreement with the Dutch company Harbour Antibodies, allowing the Chinese company to develop therapeutic antibody candidates for its customers using Harbour's transgenic mouse-based antibody development technology. More

> PPD has entered an alliance with the Global Allergy and Asthma European Network, giving the CRO access to the organization's allergy and asthma experts and more than 100 research sites in Europe. Article

> Xcelience has opened a 24,000-square-foot facility in Tampa, FL, to boost its primary and secondary packaging, labeling, distribution and warehouse services. Story

> The CMO market is poised to grow 6% each year, and an increase in demand for API production will drive that expansion, according to a new report from Visiongain. Report

> Celerion achieved accreditation from the Association for the Accreditation of Human Research Protection Programs for its facilities, making it the first U.S. CRO to do so. Release

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.